Key result
Low-dose aspirin is recommended to prevent stroke and death in ischemic cerebrovascular disease pending ongoing trials.
Why the study?
Does low-dose aspirin compared to high-dose aspirin provide optimal prevention of stroke and death in patients with ischemic cerebrovascular disease?
Population
Patients with ischemic cerebrovascular disease
Comparison
Low-dose aspirin (75 mg daily) vs High-dose aspirin (650 to 1300 mg daily)
Design
Review
Authors
Loading...
Supports interim low-dose aspirin use in ischemic cerebrovascular disease; leaves open optimal dosing versus higher regimens pending trials.
Does low-dose aspirin compared to high-dose aspirin provide optimal prevention of stroke and death in patients with ischemic cerebrovascular disease?
The review recommends using low-dose aspirin (75 mg daily) for stroke prevention in ischemic cerebrovascular disease due to lack of definitive evidence for higher doses.
Gerald J. Roth (1996) conducted a review in Ischemic Cerebrovascular Disease. Aspirin vs. Higher doses (650 to 1300 mg) was evaluated on Prevention of stroke and death. Aspirin at a low dose of 75 mg daily is recommended for the prevention of stroke and death in patients with ischemic cerebrovascular disease, pending definitive evidence from ongoing trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: